2 research outputs found

    Critical Care Management of a Severe Acute Respiratory Distress Syndrome COVID-19 Patient With Control Cesarean Section

    Get PDF
    We share our experience of one 29-year-old female, G2 P1, with acute respiratory distress syndrome (ARDS) and at 30 weeks of pregnancy. The 30-week gravid uterus in combination with a poor ventilation-perfusion ratio creates a restrictive lung pattern that may prove to be lethal for both the mother and baby. Due to her rapid deterioration and increased hemodynamic instability we opted for controlled delivery in the operating room with an ICU physician, a Neonatologist, and an Obstetric team. At 3.27 minutes from induction, the baby was born with Apgar scores of 7 and 8. The mother was placed on a RotoProne® bed, treated with remdesivir, steroids, and was subsequently extubated seven days later. The newborn was admitted to the Neonatal Intensive Care Unit (NICU) after delivery. We have reviewed the literature and provided a concise set of recommendations based on our field experience and current world literature review. Prompt delivery in a controlled environment with multiple resuscitating teams provided expeditious treatment of both patients, maintaining oxygenation and perfusion while keeping hemodynamic stability. The controlled environment and the proximity of all teams avoided deleterious consequences to the unborn baby. This is an example where the risk of keeping the baby in the womb outweighs the premature delivery into a NICU. Both mother and baby were downgraded from their respective Intensive Care Units (ICUs) and discharged home in one month

    In-hospital mortality rate and predictors of 30-day readmission in patients with iron deficiency anemia and diastolic heart failure : a cross-sectional study

    Get PDF
    Corresponding author: Karthik Gangu MD, Assistant Professor of Clinical Medicine, Department of Medicine, Division of Hospital Medicine, University of Kansas Medical CenterIntroduction: There is currently strong evidence of the adverse effects of anemia on the prognosis of heart failure with reduced ejection fraction. Unfortunately, the data on the effects of anemia on a large sample of patients with diastolic heart failure (DHF) is lacking. In this study, we aimed to evaluate the effect of iron deficiency anemia on DHF readmission rates and its corresponding causes and burdens on the healthcare system. Methods: We utilized 2018 Nationwide readmission data and included patients aged ≥18 years with ICD-10 CM code indicating acute or acute chronic diastolic heart failure and iron deficiency anemia was included in the study. The primary outcome is 30-day readmission rates. Secondary outcomes were mortality rates, common causes of readmission, and healthcare utilization. Independent predictors for readmission were identified using cox regression analysis. Results: The total number of admissions in our study was 795,777. The mean age was 74.4 years (SD=13.7), and 63.54% were females. The 30-day readmission rate in patients with diastolic heart failure and iron deficiency anemia was 18.32 % vs. 16.01% in patients without anemia. The mortality rate at index admission and readmission was 3.62 % (2601) and 5.82 % (737), respectively. The most common cause of readmission was hypertensive heart and kidney disease with heart failure (17.74%). The independent predictors of readmission were age [less than] 85 years, household income [less than] 59000/peryear,MedicareandMedicaidinsurance,higherElixhausercomorbiditiesscore,longerLengthofstayduringtheindexadmission,dischargetoanursinghome,hospitallocatedinalargemetropolitanarea.Thefinancialburdenonhealthcareforallthereadmissionwas/per year, Medicare and Medicaid insurance, higher Elixhauser comorbidities score, longer Length of stay during the index admission, discharge to a nursing home, hospital located in a large metropolitan area. The financial burden on healthcare for all the readmission was 837 million for 2018. Conclusion: The 30-day readmission rate in patients with diastolic heart failure and iron deficiency anemia is 18.32% in the year 2018. The mortality rate increased from 3.62 % to 5.82 % with readmission. The financial burden for readmission during that year was $837 million. Future studies are warranted to treat iron deficiency anemia to prevent readmissions in diastolic heart failure.Karthik Gangu MD (Department of Medicine, Division of Hospital Medicine, University of Kansas Medical Center), Aniesh Bobba MBBS (Department of Medicine, Division of Hospital Medicine, John H Stroger Hospital of Cook County), Parth S.Patel MD (University of Missouri Kansas City School of Medicine), Sruthi Vellanki MD (Department of Medicine, Division of Hospital Medicine, Union Hospital), Anup Kumar Trikannad MD (Department of Medicine, Division of Hospital Medicine, Union Hospital), Sanket Basida MBBS (Department of Medicine, Pandit Deendayal Upadhyay Medical College), Sindhu Avula (Department of Cardiovascular Medicine, Division of Interventional Cardiology, University of Kansas Medical Center), Alok Tripathi (Department of Cardiovascular Medicine, Division of Interventional Cardiology, University of Kansas Medical Center)Includes bibliographical references
    corecore